Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Letairis (Ambrisentan) Tablets
Company:  Gilead Sciences, Inc.
Application No.:  022081
Approval Date: 06/15/2007


Date created:  August 21, 2007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.